BCBA/XROX (BCBA/XROX)

Buenos Aires Stock Exchange: BCBA/XROX · ARS

ARS 4,158

-102.67 (-2.4%)· Recorded snapshot

Market cap	513B
Revenue (ttm)	11.5T
Net income (ttm)	-1.4T
EPS (ttm)	-ARS 11,240
P/E (forward)	7.8x
Dividend	ARS 120 (2.88%)
Volume	1,149

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11.5T
Net income (ttm): -1.4T
EPS (ttm): -ARS 11,240
P/E (forward): 7.8x
Market cap: 513B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E7.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-97.1

P25 n/aP50 n/aP75 n/a

ROIC3.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/XROX indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-29
Employees	23,000
Employees change	6,100
Employees growth	36.31%
Enterprise value	ARS 6.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1903
Industry	Business Equipment & Supplies
Is primary listing	No
ISIN number	ARBCOM4600W4
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	ARS 513B
Next earnings date	2026-10-29
Price	ARS 4,157.50
Price currency	ARS
Sector	Industrials
SIC code	3577
Stock price date	2026-10-27
Symbol	bcba/XROX
Website	https://www.xerox.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-270.37%
EV/EBIT	30.43x
EV/EBITDA	8.4x
EV/FCF	41.75x
EV/Sales	0.56x
FCF / EV yield	2.4%
FCF yield	31.48%
Forward P/E	7.84x
P/(FCF - SBC) ratio	4.81x
P/(OCF - SBC) ratio	1.92x
P/B ratio	0.63x
P/FCF ratio	3.18x
P/OCF ratio	1.6x
P/S ratio	0.04x
Price/EBITDA ratio	0.66x
Sector P/E	9.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.86%
EBITDA margin	6.73%
FCF margin	1.35%
Gross margin	30.55%
Operating margin	1.86%
Pretax margin	-5.2%
Profit margin	-11.92%
Profit per employee	ARS -60.5M
Profitable quarters	1
Revenue per employee	ARS 499.7M
ROA	0.97%
ROA (5Y)	1.17%
ROCE	2.18%
ROE	-97.11%
ROE (5Y)	-37.08%
ROIC	3.29%
ROIC (5Y)	3.36%
SBC / revenue	0.48%
Tax / revenue	6.73%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
FCF growth	-66.77%
FCF growth 3Y	-28.8%
FCF growth 5Y	-29.21%
Gross profit growth	24.47%
Gross profit growth (Q)	49.24%
Gross profit growth 3Y	-0.65%
Gross profit growth 5Y	-1.27%
Net income growth quarters	1
Net income growth years	1
OCF growth	-40.87%
OCF growth 10Y	-16.4%
OCF growth 3Y	-14.81%
OCF growth 5Y	-20.23%
Operating income growth	33.33%
Operating income growth (Q)	400%
Operating income growth 3Y	-28.62%
Operating income growth 5Y	-19.39%
Revenue growth	25.64%
Revenue growth (Q)	21.95%
Revenue growth (QoQ)	4.12%
Revenue growth 10Y	-0.07%
Revenue growth 3Y	2.7%
Revenue growth 5Y	1.5%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -160B
Depreciation and amortization	ARS 581.5B
EBIT	ARS 213.3B
EBITDA	ARS 773.3B
EPS	ARS -11,240.49
Financing cash flow	ARS 108.1B
Free cash flow	ARS 161.5B
Free cash flow minus SBC	ARS 106.7B
Gross profit	ARS 3.5T
Income taxes	ARS 773.3B
Investing cash flow	ARS -1.1T
Net borrowing	ARS 43.1B
Net cash flow	ARS -641.5B
Net income	ARS -1.4T
Operating cash flow minus SBC	ARS 266.7B
Operating income	ARS 213.3B
Revenue	ARS 11.5T
Stock-based compensation	ARS 54.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.28
Book value per share	ARS 3,646.09
Debt / EBITDA	8.26
Debt / equity	7.79
Debt / FCF	39.57
Goodwill	ARS 3.4T
Interest coverage	0.42
Long-term assets	ARS 8.7T
Long-term liabilities	ARS 8.8T
Net cash (debt)	ARS -5.7T
Net cash / market cap	-1,102.5%
Net debt / EBITDA	7.31
Net debt / equity	6.89
Net debt / FCF	35.03
Piotroski F-Score	4
Property, plant and equipment	ARS 581.5B
Shareholders' equity	ARS 820.8B
Tangible book value	ARS -4.1T
Tangible book value per share	ARS -31,245.80
Total assets	ARS 14.4T
Total cash	ARS 733.3B
Total debt	ARS 6.4T
Total liabilities	ARS 13.6T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.83
Current assets	ARS 5.7T
Current liabilities	ARS 4.8T
Current ratio	1.18
Inventory turnover	5.63
Net working capital	ARS 216.3B
Quick ratio	0.69
Working capital	ARS 845.9B
Working capital turnover	13,616.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3%
Dividend growth	-58.28%
Dividend growth (3Y)	-15.81%
Dividend growth (5Y)	16.03%
Dividend growth years	0
Dividend payment date	2026-10-30
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	ARS 119.91
Dividend yield	2.88%
Ex-dividend date	2026-09-30
Last dividend	ARS 38.13
Shareholder yield	-0.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 4,217.43
1D price change	-2.41%
1M price change	-22.29%
1M total return	-21.72%
1W price change	3.94%
1W total return	3.94%
1Y price change	-26.09%
1Y return CAGR	-23.59%
1Y total return	-23.58%
20-day SMA	ARS 4,548.00
200-day SMA	ARS 3,938.55
3M price change	0.48%
3M total return	1.22%
3Y price change	-61.33%
3Y return CAGR	-24.56%
3Y total return	-57.08%
50-day SMA	ARS 4,885.15
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 5,880.00
52-week high date	2026-07-30
52-week low	ARS 1,740.00
52-week low date	2026-04-13
5Y price change	-0.25%
5Y return CAGR	2.76%
5Y total return	14.6%
6M price change	75.64%
6M total return	77.78%
All-time high	ARS 25,063.00
All-time high date	2024-01-30
All-time low	ARS 1,308.50
All-time low date	2019-08-09
Average true range (ATR)	ARS 245.85
Average volume	3.7K
Change from 52-week high	-29.29%
Change from 52-week low	138.94%
Change from all-time high	-83.41%
Change from all-time low	217.73%
Change from open	0.42%
Day's gap	-2.82%
Dollar volume	ARS 4.8M
High price	ARS 4,247.50
Low price	ARS 4,140.00
Monthly RSI	41.7
Open price	ARS 4,140.00
Position in 52-week range	16.28%
Previous close	ARS 4,260.00
Price vs 150-day SMA	-1.42%
Price vs 20-day SMA	-8.59%
Price vs 200-day SMA	5.56%
Price vs 50-day SMA	-14.9%
Relative volume	0.31
RSI	38.58
Sharpe ratio	0.29
Sharpe ratio (3Y)	-0.14
Sharpe ratio (5Y)	0.46
Sortino ratio	0.62
Sortino ratio (3Y)	-0.14
Sortino ratio (5Y)	0.81
Volume	1.1K
Weekly RSI	45.35
YTD price change	13.98%
YTD total return	16.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	118M
Shares change (QoQ)	4.5%
Shares change (YoY)	3%
Shares held by insiders	3.63%
Shares held by institutions	78.08%
Short ratio	12.4 days

Deeper analysis on BCBA/XROX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/XROX report

Is a complete BCBA/XROX research report available?

No complete published report is available for bcba/XROX (BCBA/XROX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/XROX (BCBA/XROX)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/XROX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/XROX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/XROX

Frequently asked questions